Psioasis Biogen Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 19 Days
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 567.31%
- Profit Growth 48.06%
- Ebitda -190.08%
- Net Worth -103.49%
- Total Assets 395.67%
About Psioasis Biogen
Psioasis Biogen Private Limited (PBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 25 January 2016 (Nine years 19 days old ). Its registered office is in Bhavnagar, Gujarat, India.
The Corporate was formerly known as Psioasis Chemical Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jai Chaudhary, Satyaprakash Yadav, and Sukumar Ghara serve as directors at the Company.
Company Details
-
Location
Bhavnagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2016PTC085812
-
Company No.
085812
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2016
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Psioasis Biogen Private Limited offer?
Psioasis Biogen Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Emulsifiers, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Psioasis Biogen?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jai Chaudhary
|
Director | 25-Jan-2016 | Current |
|
Satyaprakash Yadav
|
Additional Director | 26-Jul-2022 | Current |
|
Sukumar Ghara
|
Additional Director | 26-Jul-2022 | Current |
Financial Performance of Psioasis Biogen.
Psioasis Biogen Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 567.31% increase. The company also saw a substantial improvement in profitability, with a 48.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 103.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psioasis Biogen?
In 2019, Psioasis Biogen had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Psioasis Biogen?
Unlock and access historical data on people associated with Psioasis Biogen, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psioasis Biogen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psioasis Biogen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
